|
 |
 |
 |
 |
 |
 |
 |
| • Request A Quote |
|
| • Place An Order |
|
| • Pricing |
|
| • Shipping |
|
| • Warranty |
|
| • Specifications |
 |
|||
 |
Kononen, J., Bubendorf, L., Kallioniemi, A., Barlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., and Kallioniemi, O. P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med, 4: 844-847,1998
Camp, R. L., Charette, L. A., and Rimm, D. L. Validation of tissue microarray technology in breast carcinoma. Lab Invest, 80: 1943-1949, 2000 Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., and Chinnaiyan, A. M. Delineation of prognostic biomarkers in prostate cancer. Nature, 412: 822-826, 2001 Fejzo, M. S. and Slamon, D. J. Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins. Am J Pathol, 159: 1645-1650, 2001 Hewitt SM. The application of tissue microarrays in the validation of microarray results.Methods Enzymol. 410: 400-415, 2006 Brennan DJ, Kelly C, Rexhepaj E, Dervan PA, Duffy MJ, and Gallagher WM. Contribution of DNA and tissue microarray technology to the identification and validation of biomarkers and personalised medicine in breast cancer.Cancer Genomics Proteomics. 4: 121-134, 2007 Takikita M, Chung JY, and Hewitt SM. Tissue microarrays enabling high-throughput molecular pathology. Curr Opin Biotechnol. 18: 318-25, 2007 |
||
Search | Privacy | Legal Copyright © 2007 Veridiam. All Rights Reserved |
|||